Burnett Patrick bought ARQT
August 18, 2022 · Form 4 insider transaction
Burnett Patrick bought 16,750 shares of Arcutis Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1293 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,750
Price
$0.00
Total value
N/A
InsiderBurnett Patrick
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateAugust 18, 2022
Filing dateMarch 3, 2026
Shares owned after97,401
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On August 8, 2020, the Reporting Person was granted performance-based Restricted Stock Units ("RSUs") subject to a milestone condition. The Compensation Committee of the Issuer certified the achievement of the milestone and commencement of vesting on August 18, 2022. The remaining RSUs vested in three substantially equal annual installments, such that the RSUs fully vested on August 18, 2025.; Reflects holdings following the August 18, 2022 transaction reported herein.